What We Do

Picture of a sunset at Bondi Beach
 

ReSQ Clinical Research Pty Ltd is an Australian Contract Research Organisation (CRO) established in 2007 and based in Bondi, Sydney. Inspired by the natural beauty of iconic Bondi Beach, and deeply respectful of the land on which we work and live, we have adopted the pituri flower as our logo. The traditional owners of our land had a deep understanding of the medicinal value of plants. We pay our respect to their healers as we work tirelessly to relieve suffering and help people live long and healthy lives.

We offer:

  • Strategic and day-to-day operational support for drug and device trials for local and overseas pharmaceutical and device sponsors, start-ups, and CROs

  • Strong personal relationships with sites and sponsors

  • Local experience in site selection from a trusted network of investigators across a wide range of therapeutic areas

  • Deep understanding of local regulatory environment, and a proven track record of ensuring efficient regulatory and ethical approval timelines

Our experienced professionals work collaboratively with local and global sponsors and investigator sites to ensure patients have access to innovative treatment.

 

Areas of Expertise

Picture of the Pituri Bush, the inspiration for the ReSQ Clinical Research Logo
 

Phases I-IV, First in Man Studies, Registries and Observational Studies

Drug Development

  • Psychiatry: depression, schizophrenia, ADHD, borderline personality disorder, anxiety disorders, bipolar disorder, treatment of resistant depression, obsessive compulsive disorder, minimal cognitive impairment

  • Endocrinology: diabetes, hormone replacement therapy

  • Cardiovascular: hypertension, congestive heart failure

  • Obesity

  • Antibiotics: pneumonia, bronchitis, otitis media, skin and soft tissue infections

  • Respiratory: asthma

  • Gastroenterology: gastric and duodenal ulcers

  • Oncology: Phase I-III

  • Urinary: stress urinary incontinence

  • Dermatology: acne

  • Neurology: progressive supranuclear palsy, stroke

  • Rare diseases: growth hormone deficiency, achondroplasia, Morquio-A

  • Other: immunosuppressant agents, vaccines, critical care, allergic conjunctivitis, pain management, haemophilia, cannabinoids, NASH, neuro-stimulation

Device Development

  • Contact lenses

  • Cardiac devices: bare metal stents, drug eluting stents, bifurcation stents, implantable pulse generators, renal denervation

  • Vascular devices: drug eluting balloons, AAA stents, devices to treat PAD and chronic venous insufficiency

  • Diabetes pumps